Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze DD stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate DD investment potential.

What is DD stock price today?

Get real-time DD stock price, historical data, and price charts on Financhill. Track DD performance with our advanced analysis tools.

Is DD a good investment?

Evaluate DD investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

To buy DD stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of DD?

View detailed market capitalization data and company valuation metrics for DD on our comprehensive analysis page.

What is the P/E ratio of DD?

Use our fundamental analysis tools to view DD P/E ratio and compare valuation metrics with industry peers.

What are DD earnings?

View DD earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

DuPont de Nemours, Inc. 10K Form

Buy

DD
DuPont de Nemours, Inc.

Last Price:

$39.83

Seasonality Move:

1.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2025-11-15	10K	DD/DuPont de Nemours, Inc. Annual
2025-10-15	10K	DD/DuPont de Nemours, Inc. Annual
2025-09-15	10K	DD/DuPont de Nemours, Inc. Annual

Receive DD News And Ratings

See the #1 stock for the next 7 days that we like better than DD

DD Financial Statistics

Sales & Book Value

Annual Sales:	$12.4B
Cash Flow:	$532M
Price / Cash Flow:	13.21
Annual Sales:	$54.66
Price / Book:	0.73

Profitability

EPS (TTM):	-1.84250
Net Income (TTM):	$-63M
Gross Margin:	$3.9B
Return on Equity:	-0.27%
Return on Assets:	-0.17%

DuPont de Nemours, Inc. Earnings Forecast

Key DuPont de Nemours, Inc. Financial Ratios

The Gross Profit Margin over the past 45 years for DD is 31.58%.
The Selling, General & Administrative Expenses for DD have been equal to 12.53% of Gross Profit Margin.
The Research & Development expenses have been 4.29% of Revenue.
The Interest Expense is 47.04% of Operating Income.
The Net Earning history of DD is 6.28% of Total Revenues.
Per Share Earnings over the last 45 years have been positive in 21 years.

DuPont de Nemours, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	S&P500
Industry:	Chemicals
Sector:	Materials
Current Symbol:	DD
CUSIP:	26614N
Website:	dupont.com

Debt

Debt-to-Equity Ratio:	0.4
Current Ratio:	2
Quick Ratio:	1.09

Price-to-Earnings

Trailing P/E Ratio:	23.82
Forward P/E Ratio:	18.43

DD Technical Analysis vs Fundamental Analysis

Buy

DuPont de Nemours, Inc. (DD) is a Buy

Is DuPont de Nemours, Inc. a Buy or a Sell?

DuPont de Nemours, Inc. stock is rated a Buy

The current DuPont de Nemours, Inc. [DD] share price is $39.82. The Score for DD is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.